5 Results for "

GVIA iPLA2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "GVIA iPLA2" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-115403
CAS No.: 1071001-09-6
Purity:  ≥99.0%
Target:  

Phospholipase Apoptosis

Research Areas:  

Metabolic Disease

FKGK18 is a selective group VIA calcium-independent phospholipase A2 (GVIA iPLA2) inhibitor. FKGK18 is a fluoroketone (FK)-based compound with IC50s of 50 nM and 3 μM for iPLA2β and iPLA2γ. FKGK18 can be used for the research of beta-cell apoptosis and diabetes .
loading...
    loading...
Cat. No.: HY-116018
CAS No.: 1071000-98-0
FKGK11 is a potent and selective inhibitor of GVIA iPLA2 (Group VIA calcium-independent phospholipase A2). FKGK11 can be used for the research of ovarian cancer and neurological disorders such as peripheral nerve injury and multiple sclerosis .
loading...
    loading...
Cat. No.: HY-125986
CAS No.: 1071001-50-7
Purity:  ≥98.0%
Target:  

Phospholipase

Research Areas:  

Neurological Disease

GK187 is a potent and selective Group VIA calcium-independent phospholipase A2 (GVIA iPLA2) inhibitor with an XI(50) value of 0.0001. GK187 can be used for researching various neurological disorders .
[The XI(50) is the mole fraction of the inhibitor in the total substrate interface required to inhibit the enzyme by 50%.]
loading...
    loading...
Cat. No.: HY-138990
CAS No.: 2351820-19-2
Target:  

Phospholipase Apoptosis

Research Areas:  

Inflammation/Immunology

GK563 is a selective Ca 2+-independent phospholipase A2 (GVIA iPLA2) inhibitor with an IC50 value of 1 nM. GK563 is 22000 times more active against GVIA iPLA2 than GIVA cPLA2. GK563 reduces β-cell apoptosis induced by proinflammatory cytokines, raising the possibility that it can be beneficial in countering autoimmune diseases, such as type 1 diabetes .
loading...
    loading...
Cat. No.: HY-126072
CAS No.: 1983928-04-6
Target:  

Drug Isomer

Research Areas:  

Others

(Rac)-GK563 is the isomer of GK563 (HY-138990). GK563 is a Ca 2+-independent group VI phospholipase A2 (GVIA iPLA2) inhibitor .
loading...
    loading...